Get more Mail & Guardian
Subscribe or Login

[VIDEO] Keep calm & jab on: These numbers will boost your faith in Covid-19 vaccines

Getting a vaccine may mean that you experience some side effects. 

This is because the jabs are helping prime your body to fight off infection. 

With Covid vaccines, common side effects are quite mild and include things like pain at the injection site or a headache. 

But occasionally more severe reactions can occur. 

A common side effect occurs in 1 out of every 10 vaccinated people. 

An uncommon side effect is seen in anywhere from between 1 in 100 to 1 in 1000 people who get a jab. 

A very rare event occurs in less than 1 person for every 10 000 who are vaccinated. These very infrequent effects tend to be more severe. 

Because they occur in so few people, trials normally don’t catch these cases. 

Instead, the symptoms show up in real-life roll-outs, which reach millions of people, as opposed to the thousands who participate in studies. 

Here’s a look at rare side effects: 

1. Anaphylaxis (allergic reaction) 

Some people experience a severe allergic reaction, known as anaphylaxis, after receiving their Covid jab. 

By January, there were 50 reported cases of anaphylaxis in the United States out of the 9 943 247 Pfizer/BioNTech doses administered. This is equal to 5 cases for every million doses.

In South Africa’s Sisonke study, which used the Johnson & Johnson jab, 1 case of anaphylaxis was reported at the time that 289 787 people had gotten the shot. 

In most cases, people began to experience symptoms about 30 minutes after being vaccinated. 

For this reason, people are encouraged to remain at the vaccination site for 15 minutes to see if they develop an allergic reaction. 

Those with a history of severe allergic reactions should wait up to 30 minutes before leaving. 

If you have a known allergy to any of the vaccine ingredients then you should not be immunised with that jab. 

2. Thrombosis with thrombocytopenia (blood clots) 

Some people who received the Johnson & Johnson jab developed thrombosis with thrombocytopenia syndrome (TTS) which causes a rare type of blood clots. 

These clots are unusual because they’re coupled with a shortage of blood cells that help your body form blood clots. 

As of May, there had been 28 cases of TTS reported among the 8.73 million people in the United States who received the Johnson & Johnson vaccine. 

Women, particularly those between the ages of 30 and 49, were at the highest risk of developing these clots. 

Overall, about three in every million vaccinated people in the US reported clots. This increased to 12 in every million for women in their 30s. 

In most cases, symptoms begin to appear within one to two weeks post-vaccination. No cases of these clots have yet been reported in those who received the Pfizer vaccine.

3. Myocarditis (heart inflammation) 

The US Centres for Disease Control (CDC) is currently investigating cases of heart inflammation in people who have received the Pfizer and Moderna Covid vaccines. 

This condition, called myocarditis, usually occurs when the body’s immune system responds to an infection. 

Symptoms can include chest pain, shortness of breath or palpitations.

There have been increasing reports of this condition in people who have received the Pfizer and Moderna jabs since April. 

The exact number of cases reported has not yet been disclosed, but the CDC says it is mainly affecting young men aged 16 and up. 

Symptoms start to appear about four days after vaccination and are more common after receiving the second dose.

This story was produced by the Bhekisisa Centre for Health Journalism. Sign up for the newsletter.

Subscribe to the M&G

Thanks for enjoying the Mail & Guardian, we’re proud of our 36 year history, throughout which we have delivered to readers the most important, unbiased stories in South Africa. Good journalism costs, though, and right from our very first edition we’ve relied on reader subscriptions to protect our independence.

Digital subscribers get access to all of our award-winning journalism, including premium features, as well as exclusive events, newsletters, webinars and the cryptic crossword. Click here to find out how to join them.

Aisha Abdool Karim
Aisha Abdool Karim is a senior health reporter at Bhekisisa.
Joan van Dyk
Joan Van Dyk
Joan van Dyk graduated with an honours degree in journalism from Stellenbosch University in 2017. She was the top performing student in the class of 2016.

Related stories

WELCOME TO YOUR M&G

If you’re reading this, you clearly have great taste

If you haven’t already, you can subscribe to the Mail & Guardian for less than the cost of a cup of coffee a week, and get more great reads.

Already a subscriber? Sign in here

Advertising

Subscribers only

R350 relief grant will be paid into bank accounts or...

There are concerns that post office branch closures will make it difficult for beneficiaries to access the grant

South Africa at risk of spillover from international inflation, economists...

Higher international oil prices, for example, could affect local transport costs through second-round effects

More top stories

Companies affected by unrest can apply for support as soon...

Labour Minister Thulas Nxesi urges employers to be honest when applying for help

Mboweni extends R38bn to cope with double calamity of Covid-19...

The finance minister extended the Ters relief and the social distress relief grant, and also ensured businesses hit by looting can access insurance

South Africa appalled that Israel given AU observer status

The international relations department has released a statement condemning the decision

Coal on a drive to delay its demise

The just transition that is currently being executed is a balance between energy security and climate change, according to one analyst
Advertising

press releases

Loading latest Press Releases…
×